Target intelligence / Profile preview

Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma (PIK3CG)

Target
PIK3CG
Molecular classification
Enzyme, Kinase, Transferase
01

Overview

Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma (PIK3CG), also known as PI3Kγ or p110γ, is a class IB phosphoinositide 3-kinase (PI3K) that plays a crucial role in immune cell signaling, inflammation, and cardiovascular function. Unlike class IA PI3Ks, which are primarily activated by receptor tyrosine kinases, PI3Kγ is uniquely activated by G-protein coupled receptors (GPCRs) via Gβγ subunits. It phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3), which recruits downstream effectors like AKT to promote cell survival, growth, and migration. In the tumor microenvironment, PI3Kγ is highly expressed in myeloid cells, such as tumor-associated macrophages (TAMs), where it promotes an immunosuppressive M2-like phenotype that helps tumors evade immune surveillance. Consequently, targeting PI3Kγ with selective inhibitors like eganelisib (IPI-549) or dual inhibitors like duvelisib is a promising therapeutic strategy to reprogram the tumor microenvironment, enhance anti-tumor immunity, and overcome resistance to immune checkpoint inhibitors. However, therapeutic targeting of PI3K isoforms is associated with notable safety concerns, including autoimmune-like toxicities such as colitis, pneumonitis, and hepatotoxicity, as well as metabolic side effects.

Other names
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoformPI3-kinase subunit gammaPI3K-gammaPI3Kgammap110gammap110-gammaPhosphoinositide-3-kinase catalytic gamma polypeptideSerine/threonine protein kinase PIK3CGp120-PI3K
02

Mechanism of action

Selective inhibition of PI3K-gamma or dual inhibition of PI3K-delta and PI3K-gamma to disrupt downstream AKT signaling, reprogram tumor-associated macrophages, and reduce inflammatory cell migration.

03

Biological functions

Signal transductionImmune responseCell migrationCell proliferationCell survivalInflammatory response
04

Disease associations

CancerInflammationCardiovascular diseaseInfection
05

Safety considerations

Autoimmune colitisHepatotoxicityPneumonitisInfection riskHyperglycemiaHypertensionNeutropenia
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

PIK3CG expression levelPhospho-AKT (S473) levelsMyeloid-derived suppressor cell (MDSC) infiltrationTumor-associated macrophage (TAM) polarization (M1/M2 ratio)

Beyond the preview

Go deeper on Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma (PIK3CG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma (PIK3CG).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call